Abstract
The present invention relates to a cleavable linker platform. In particular, the invention relates to construction of an enzyme cleavable linker platform conjugated to a drug or a diagnostically relevant compound, a biomolecule, and an enzyme cleavable group, for which cleavage of the enzyme cleavable group leads to release of the drug or diagnostically relevant compound.
Original language | English |
---|---|
IPC | A61P 35/ 00 A I |
Patent number | WO2020260597 |
Filing date | 26/06/2019 |
Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
Priority date | 26/06/2019 |
Priority number | EP20190182641 |
Publication status | Published - 30 Dec 2020 |